GLP-1 Medications & Mental Health: 14 Best Practices

Make the decision from a place of bodily autonomy—not shame.

Taking a GLP-1 does not require believing that your body is unacceptable, that thinness is morally preferable, or that you have failed at body acceptance. Likewise, declining medication is a legitimate choice. A useful question is:

What am I hoping this treatment will make possible in my life?

Explore eating disorder (ED) and dieting history before beginning.

Talk honestly with your therapist and prescriber about restriction, binge eating, purging, compulsive exercise, chronic dieting, food obsession, body checking, over exercising or other disordered behaviors—even if they occurred years ago or were never formally diagnosed. Current expert recommendations specifically support screening for both past and present ED symptoms.

Establish measures of wellbeing that aren't the scale.

Consider pain, mobility, energy, sleep, laboratory markers, physical function, ability to participate in meaningful activities, relationship with food, “food noise”/obsessive thoughts about food, and overall quality of life. Weight may change, but it does not have to become the organizing principle of treatment.

You don't have to start weighing yourself.

For someone with an ED or chronic-dieting history, frequent weighing can turn a medical intervention into another dieting project. A clinician can monitor weight when medically necessary without making the number a central part of your daily life.

Be wary when “health behaviors” start becoming compulsions.

Protein, hydration, movement, strength training, and adequate nutrition matter during GLP-1 treatment. But someone can turn protein goals, step counts, gym sessions, calories, supplements, or “clean eating” into another system of rigid control. Contemporary guidance supports adequate nutrition and preserving physical function while also recognizing psychological and identity-related risks during treatment.

Learn the difference between satiety and restriction.

From the outside, these can look identical:

Therapy can help you become curious about that difference rather than assuming that eating less automatically represents either recovery or pathology/sign of a problem.

Pay attention to what happens to food noise.

A reduction in persistent thoughts about food can be profoundly meaningful for some people. It shouldn't automatically be interpreted as pathological appetite suppression. Conversely, disappearing hunger, regularly forgetting or avoiding food, or deriving satisfaction from how little one can eat deserves attention. Emerging literature explicitly identifies food preoccupation/reward as an important psychological domain while warning that appetite suppression can also facilitate restriction in vulnerable individuals, specifically those with a history of disordered eating or those who may be at risk of developing it.

Don't moralize food—even when your food preferences change.

GLP-1s can change what tastes appealing, how much feels comfortable, and how particular foods affect someone physically. “That doesn't make my body feel very good anymore” is different from “that food is bad and I shouldn't eat it.” Therapy can help preserve that distinction.

Let movement be about inhabiting the body, not shrinking it.

Strength, mobility, balance, pleasure, rehabilitation, endurance, pain reduction, and simply enjoying what the body can do are legitimate reasons to move! Exercise becoming compensation for eating or a way of accelerating weight loss may be the sign of a larger concern to discuss in therapy or with other support.

Keep therapy interested in what the medication changes psychologically—not merely whether it produces weight loss.

Changes in appetite and food reward can expose surprising territory: identity, coping, grief, pleasure, social connection, body image, sexuality, visibility, stigma, fear of weight regain, and even questions such as “Who am I when food isn't occupying this much mental space?” Recent consensus guidance specifically recognizes these psychological and identity changes as part of GLP-1 care.

Don't let other people's ideology substitute for your own experience.

Clients may encounter messages ranging from “weight loss is always good” to “intentional weight loss is inherently harmful.” Therapy should be one place where neither position has to be adopted wholesale. Someone can retain what they learned from HAES, fat liberation, body neutrality, or ED recovery and decide that a medication is helping them. Those positions don't have to cancel one another.

Watch for old ED patterns wearing new clothes.

Potential warning signs might include escalating restriction, fear of eating adequately, pride in tolerating extreme hunger, compulsive weighing/body checking, increasing exercise despite injury or exhaustion, obsession with maximizing weight loss, anxiety about dose increases primarily because of weight outcomes, or withdrawal from social situations involving food. These warrant discussion with the therapist and medical team rather than secrecy or shame. Current expert recommendations emphasize ongoing ED monitoring precisely because GLP-1-related changes can potentially mask or amplify disordered patterns.

Build an interdisciplinary team when possible.

The therapist shouldn't be managing medication, and the prescriber shouldn't necessarily be expected to recognize every psychological shift. Ideally, the client, prescriber, therapist, and—when useful—an ED-informed dietitian communicate rather than working in isolated silos. Multidisciplinary care is increasingly emphasized in GLP-1 guidance and can be vital to ongoing health.

Allow contradictory truths to coexist.